May 16, 2019
Check-Cap to Present Data at Digestive Disease Week® Demonstrating Substantial Improvement in Precancerous Polyp Detection
May 13, 2019
Check-Cap Reports First Quarter 2019 Financial Results
May 13, 2019
Check-Cap Announces Second Trial Site Joins Ongoing U.S. Pilot Study of C-Scan®
Apr 08, 2019
Check-Cap Initiates U.S. Pilot Study of C-Scan® for Colorectal Cancer Screening
Mar 28, 2019
Check-Cap Reports Fourth Quarter and Full-Year 2018 Financial Results
Mar 18, 2019
Check-Cap Announces Appointment of Mira Rosenzweig as Chief Financial Officer
Feb 12, 2019
Check-Cap Announces Institutional Review Board Approval to Initiate U.S. Pilot Study of C-Scan®
Feb 07, 2019
Check-Cap Ltd. Announces Closing of $7.5 Million Registered Direct Offering
Feb 04, 2019
Check-Cap Ltd. Announces $7.5 Million Registered Direct Offering
Dec 13, 2018
Check-Cap Announces FDA Conditional Approval of IDE to Initiate U.S. Pilot Study of C-Scan®
Nov 05, 2018
Check-Cap Reports Third Quarter 2018 Financial Results
Oct 09, 2018
Check-Cap Announces IDE Submission to FDA for Its C-Scan® System
Sep 05, 2018
Check-Cap Receives Approval From the Israeli Ministry of Health to Initiate Commercial Sales in Israel of its C-Scan® System
Sep 04, 2018
Check-Cap Announces Promising Interim Results from its Ongoing Post-CE Approval Study of C-Scan® System Version 3
Aug 29, 2018
Check-Cap Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference
Jul 31, 2018
Check-Cap Reports Second Quarter 2018 Financial Results
May 22, 2018
Check-Cap Announces Publication of CE Mark Multicenter Clinical Study Results on C-Scan® in Gut
May 17, 2018
Check-Cap Reports First Quarter 2018 Financial Results
May 08, 2018
Check-Cap Announces Closing of $20.2 Million Public Offering and Full Exercise of the Underwriter's Option to Purchase Additional Securities
Apr 19, 2018
Check-Cap Regains Compliance With Nasdaq Minimum Bid Price Requirement